119 related articles for article (PubMed ID: 25046822)
1. Complete genome sequence of Salmonella enterica serovar Typhimurium VNP20009, a strain engineered for tumor targeting.
Broadway KM; Modise T; Jensen RV; Scharf BE
J Biotechnol; 2014 Dec; 192 Pt A():177-8. PubMed ID: 25046822
[TBL] [Abstract][Full Text] [Related]
2. Optimizing the restored chemotactic behavior of anticancer agent Salmonella enterica serovar Typhimurium VNP20009.
Broadway KM; Suh S; Behkam B; Scharf BE
J Biotechnol; 2017 Jun; 251():76-83. PubMed ID: 28433721
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.
Clairmont C; Lee KC; Pike J; Ittensohn M; Low KB; Pawelek J; Bermudes D; Brecher SM; Margitich D; Turnier J; Li Z; Luo X; King I; Zheng LM
J Infect Dis; 2000 Jun; 181(6):1996-2002. PubMed ID: 10837181
[TBL] [Abstract][Full Text] [Related]
4. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
Cunningham C; Nemunaitis J
Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
[TBL] [Abstract][Full Text] [Related]
5. Rescuing chemotaxis of the anticancer agent Salmonella enterica serovar Typhimurium VNP20009.
Broadway KM; Denson EA; Jensen RV; Scharf BE
J Biotechnol; 2015 Oct; 211():117-20. PubMed ID: 26200833
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Anticancer Activities and Biosafety Between
Liu X; Guo Y; Sun Y; Chen Y; Tan W; Min JJ; Zheng JH
Front Microbiol; 2022; 13():914575. PubMed ID: 35847095
[No Abstract] [Full Text] [Related]
7. Comparative analysis of gene expression: uncovering expression conservation and divergence between Salmonella enterica serovar Typhimurium strains LT2 and 14028S.
Sonego P; Meysman P; Moretto M; Viola R; Laukens K; Cavalieri D; Engelen K
Methods Mol Biol; 2015; 1231():125-35. PubMed ID: 25343862
[TBL] [Abstract][Full Text] [Related]
8. Complete genome sequence of the universal killer Salmonella enterica Serovar Typhimurium UK-1 (ATCC 68169).
Luo Y; Kong Q; Yang J; Golden G; Wanda SY; Jensen RV; Ernst PB; Curtiss R
J Bacteriol; 2011 Aug; 193(15):4035-6. PubMed ID: 21622747
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the Lewis lung carcinoma in nude mice.
Zhang Y; Zhang N; Zhao M; Hoffman RM
Oncotarget; 2015 Jun; 6(16):14625-31. PubMed ID: 25714030
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones.
Olliver A; Vallé M; Chaslus-Dancla E; Cloeckaert A
Antimicrob Agents Chemother; 2005 Jan; 49(1):289-301. PubMed ID: 15616308
[TBL] [Abstract][Full Text] [Related]
11. Short-term signatures of evolutionary change in the Salmonella enterica serovar typhimurium 14028 genome.
Jarvik T; Smillie C; Groisman EA; Ochman H
J Bacteriol; 2010 Jan; 192(2):560-7. PubMed ID: 19897643
[TBL] [Abstract][Full Text] [Related]
12. Detection of multidrug-resistant Salmonella enterica serovar typhimurium phage types DT102, DT104, and U302 by multiplex PCR.
Chiu CH; Su LH; Chu CH; Wang MH; Yeh CM; Weill FX; Chu C
J Clin Microbiol; 2006 Jul; 44(7):2354-8. PubMed ID: 16825349
[TBL] [Abstract][Full Text] [Related]
13. Reciprocally rewiring and repositioning the Integration Host Factor (IHF) subunit genes in
Pozdeev G; Beckett MC; Mogre A; Thomson NR; Dorman CJ
Microb Genom; 2022 Feb; 8(2):. PubMed ID: 35166652
[TBL] [Abstract][Full Text] [Related]
14. Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar Typhimurium DT104 and its identification in phage type DT120 and serovar Agona.
Boyd D; Peters GA; Cloeckaert A; Boumedine KS; Chaslus-Dancla E; Imberechts H; Mulvey MR
J Bacteriol; 2001 Oct; 183(19):5725-32. PubMed ID: 11544236
[TBL] [Abstract][Full Text] [Related]
15. Tumor-targeted Salmonella typhimurium overexpressing cytosine deaminase: a novel, tumor-selective therapy.
King I; Itterson M; Bermudes D
Methods Mol Biol; 2009; 542():649-59. PubMed ID: 19565926
[TBL] [Abstract][Full Text] [Related]
16. The genome of Salmonella enterica serovar Typhi.
Baker S; Dougan G
Clin Infect Dis; 2007 Jul; 45 Suppl 1():S29-33. PubMed ID: 17582565
[TBL] [Abstract][Full Text] [Related]
17. Salmonella enterica serovar Typhimurium response involved in attenuation of pathogen intracellular proliferation.
Cano DA; Martínez-Moya M; Pucciarelli MG; Groisman EA; Casadesús J; García-Del Portillo F
Infect Immun; 2001 Oct; 69(10):6463-74. PubMed ID: 11553591
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel Salmonella enterica serovar Typhimurium DT104-specific prophage and nonprophage chromosomal sequences among serovar Typhimurium isolates by genomic subtractive hybridization.
Hermans AP; Abee T; Zwietering MH; Aarts HJ
Appl Environ Microbiol; 2005 Sep; 71(9):4979-85. PubMed ID: 16151076
[TBL] [Abstract][Full Text] [Related]
19. Integrons and transposons on the Salmonella enterica serovar typhimurium virulence plasmid.
Villa L; Carattoli A
Antimicrob Agents Chemother; 2005 Mar; 49(3):1194-7. PubMed ID: 15728925
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the genes for ClpXP protease in Salmonella enterica serovar Typhimurium results in persistent infection in mice, and development of persistence requires endogenous gamma interferon and tumor necrosis factor alpha.
Yamamoto T; Sashinami H; Takaya A; Tomoyasu T; Matsui H; Kikuchi Y; Hanawa T; Kamiya S; Nakane A
Infect Immun; 2001 May; 69(5):3164-74. PubMed ID: 11292737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
